Hy-Lite Responds to Social Distancing Needs with Launch of Acrylic Block Rolling Privacy Panels
July 13, 2020 11:14 ET | Hy-Lite
PENSACOLA, Florida, July 13, 2020 (GLOBE NEWSWIRE) -- To support social distancing in medical, workplace and commercial spaces, Hy-Lite has introduced a line of Acrylic Block Rolling Privacy Panels....
Innovation Pharmaceuticals – Clinical Trial Testing of Brilacidin Against SARS-CoV-2 (COVID-19) Targeted to Commence Q4 2020
July 13, 2020 08:00 ET | Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., July 13, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provides perspectives on the planned...
Tonix2.jpg
Tonix Pharmaceuticals Enters into Research and Exclusive License Option Agreement with Kansas State University to Develop Vaccine Against COVID-19
July 13, 2020 07:00 ET | Tonix Pharmaceuticals Holding Corp.
Research to Develop Live Replicating Vaccine (TNX-2300) to Protect Against COVID-19 Based on Bovine Parainfluenza Virus TNX-2300 Will Be Tonix’s Second Live Replicating Virus Vaccine Platform ...
190705_Biontech_Logo_RGB_Dark Green (Preferred)_0.png
Pfizer und BioNTech erhalten FDA-Fast-Track-Status für zwei mRNA-basierte Impfstoffkandidaten gegen SARS-CoV-2
July 13, 2020 06:45 ET | BioNTech SE
NEW YORK und MAINZ, Deutschland, July 13, 2020 (GLOBE NEWSWIRE) -- Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX, „BioNTech”) gaben heute bekannt, dass zwei der vier in Entwicklung...
190705_Biontech_Logo_RGB_Dark Green (Preferred)_0.png
Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2
July 13, 2020 06:45 ET | BioNTech SE
NEW YORK and MAINZ, Germany, July 13, 2020 (GLOBE NEWSWIRE) -- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that two of the companies’ four investigational...
CytoDynLogo.png
Update on HIV-BLA-PDUFA: FDA requested more information to complete a substantive review. No additional trials required. CytoDyn plans to submit the requested information and will ask for a Type A meeting with the FDA per the agency’s suggestion
July 13, 2020 06:00 ET | CytoDyn Inc.
Update on COVID-19: CytoDyn is planning to lock and unblind the Phase 2 COVID-19 trial data later this week. Periodic safety review by Data Safety Monitoring Committee (DSMC) for ongoing Phase 3 study...
Equillium_Square_Logo.png
Clinical Trial Shows Itolizumab Reduces Mortality in Patients Hospitalized with COVID-19
July 13, 2020 03:30 ET | Equillium
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon Biocon has received emergency use approval from Drugs Controller General of...
junshi-topalliance-logo.png
Junshi Biosciences Announces Completion of Enrollment in Phase I Trial of SARS-CoV-2 Neutralizing Antibody JS016 in China
July 12, 2020 20:00 ET | Junshi Biosciences
SHANGHAI, China, July 12, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and...
0709-RoundClosedReleaseArt
Microshare Closes $5mn+ in Financing to Fuel Growth in Facilities Safety and Intelligence Solutions
July 09, 2020 12:00 ET | Microshare.io
PHILADELPHIA, July 09, 2020 (GLOBE NEWSWIRE) -- Defying the worst environment for raising capital in modern times, Microshare Inc. announced Thursday the successful closing of $5mn in funding with...
firstliberty.png
Breaking: U.S. Navy Reverses Course, Ends Ban on Troops Attending Indoor Religious Services
July 09, 2020 10:02 ET | First Liberty Institute
First Liberty Institute urged U.S. Navy to accommodate the religious beliefs of its service members and chaplains to attend in-person religious services  WASHINGTON, July 09, 2020 (GLOBE NEWSWIRE)...